-+ 0.00%
-+ 0.00%
-+ 0.00%

Sinopharm Hyundai (600420.SH) subsidiary's vitamin B12 injection passed generic drug consistency evaluation

Zhitongcaijing·08/18/2026 10:25:07
Listen to the news

Zhitong Finance App News, Sinopharm Hyundai (600420.SH) issued an announcement. Recently, Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. (Sinopharm Rongsheng Pharmaceutical Co., Ltd.), a wholly-owned subsidiary of the company, received the “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration to increase specifications and pass a consistent evaluation of the quality and efficacy of generic drugs.

Vitamin B12 injections are mainly used for megaloblastic anemia due to lack of internal factors, and can also be used for adjuvant treatment of subacute combined degenerative neurological diseases, such as neuritis.